Xenon Pharmaceuticals (XENE) Misses Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Join SI Premium – FREE
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($1.31), $0.12 worse than the analyst estimate of ($1.19).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
- JPMorgan Starts Metlen Energy & Metals (MTLN:LN) at Overweight
- Orosur Mining launches private placement targeting C$14M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
